PolyActiva
PrivateLast Round
Series C
May 30, 2025
Total Funding Raised
$46.39M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
PolyActiva is a biopharmaceutical company developing a biodegradable, sustained-release drug delivery platform for ophthalmic conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PolyActiva Comparables
Compare PolyActiva with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ripple Therapeutics | 83% | |
| Mati Therapeutics | 78% | |
| Ocular Therapeutix Inc | 78% | |
PolyActiva Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | May 30, 2025 | ||||
| Grant | May 7, 2024 | ||||
| VC Round | Aug 30, 2018 | ||||
| Series B | Feb 19, 2013 | ||||
| Series B | Feb 19, 2013 | ||||
Series A | Jan 1, 2011 |
PolyActiva Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CUREator | Grant |
| Yuuwa Capital | VC Round, Series B |
| National Reconstruction Fund Corporation | Series C |
| Brandon Capital | Series C, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 13, 2026
Open roles increased to 5, representing 16% of headcount.
- Jun 22, 2026
Monthly visitors grew 34% MoM.
PolyActiva Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PolyActiva's valuation, stock price, and market status.